サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654316

米国の心臓構造イメージング市場規模、シェア、動向分析レポート：モダリティ別、手術別、用途別、最終用途別、セグメント予測、2025年～2030年

U.S. Structural Heart Imaging Market Size, Share & Trends Analysis Report By Modality (Echocardiogram, Angiogram), By Procedure (TAVR, SAVR, TMVR), By Application, By End-use, By Country, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
米国の心臓構造イメージング市場規模、シェア、動向分析レポート：モダリティ別、手術別、用途別、最終用途別、セグメント予測、2025年～2030年
出版日: 2025年01月21日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の心臓構造イメージング市場動向：

米国の心臓構造イメージング市場規模は2024年に25億8,000万米ドルと推定され、2025年から2030年にかけてCAGR 5.9%で成長すると予測されます。

構造的心臓疾患の有病率の上昇、高齢化、TAVRやTMVRのような低侵襲手技の採用が増加しています。3D/4D心エコー、AI搭載診断、フュージョンイメージングなどの技術進歩により、診断と治療計画の精度と効率が向上しています。病院インフラの拡大、早期診断に対する意識の高まり、画像診断企業とヘルスケアプロバイダーとの連携が市場成長をさらに後押ししています。

米国における心臓構造イメージングの拡大は、主に心臓疾患の有病率の増加と予防検診の重視の高まりによる。大動脈弁狭窄症、僧帽弁閉鎖不全症、先天性心疾患などの構造的心臓疾患は、特にこれらの疾患に罹患しやすい高齢者層で一般的になりつつあります。これらの疾患を効果的に管理するためには、早期発見と正確な診断が不可欠であり、高度な画像診断技術に対する需要を煽っています。同時に、予防ヘルスケアの重要性に対する患者の意識も高まっています。心血管系の潜在的な問題を深刻化する前に発見するために、定期的な健康診断を選択する人が増えており、その結果、心臓構造イメージング・ソリューションへの依存度が高まっています。

シーメンス・ヘルティニアーズ、GEヘルスケア、Koninklijke Philips N.V.などの大手メーカーの存在が、米国市場の成長を大きく後押ししています。これらの業界リーダーは、正確で効率的な診断ソリューションに対する需要の高まりに応えるため、常に革新的な先進画像処理製品を発表しています。例えば、2024年8月、シーメンス・ヘルティニアーズは、人工知能（AI）機能を統合した先進の心臓血管超音波システムであるACUSON OriginのFDA認可を取得しました。この先進的なシステムは、診断精度の向上とワークフローの合理化を目的として設計されており、画像診断の成果を向上させるためにAIを活用することに業界が注力していることを示しています。新技術の開発と商品化に対するこれらの主要企業の継続的な発展は、構造的な心臓疾患の有病率の上昇に対応するだけでなく、患者ケアのための最先端のツールをヘルスケアプロバイダーに提供することによって市場の成長を強化します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の心臓構造イメージング市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 浸透と成長の見込みマッピング
  • 業界バリューチェーン分析
    • 償還枠組み
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 米国の心臓構造イメージング市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の心臓構造イメージング市場：モダリティの推定・動向分析

  • セグメントダッシュボード
  • 米国の心臓構造イメージングモダリティの市場変動分析
  • 米国の心臓構造イメージング市場の規模と動向分析、モダリティ別、2018～2030年
  • 心エコー検査
  • 血管造影検査
  • CT
  • MRI
  • 核イメージング
  • その他のモダリティ

第5章 米国の心臓構造イメージング市場：手術の推定・動向分析

  • セグメントダッシュボード
  • 米国の心臓構造イメージング手術の市場変動分析
  • 米国の心臓構造イメージング市場の規模と動向分析、手術別、2018～2030年
  • 経カテーテル大動脈弁置換術（TAVR）
  • 外科的大動脈弁置換術（SAVR）
  • 経カテーテル僧帽弁修復術（TMVR）
  • 左心耳閉鎖術（LAAC）
  • 三尖弁の置換と修復
  • 弁周囲漏出の検出と修復
  • 輪状形成術
  • 弁形成術
  • その他の構造的心臓手術

第6章 米国の心臓構造イメージング市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 米国の心臓構造イメージング用途の市場変動分析
  • 米国の心臓構造イメージング市場の規模と動向分析、用途別、2018～2030年
  • 診断画像
  • インターベンショナルカーディオロジー

第7章 米国の心臓構造イメージング市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 米国の心臓構造イメージング最終用途の市場変動分析
  • 米国の心臓構造イメージング市場の規模と動向分析、最終用途別、2018～2030年
  • 病院・診療所
    • 病院と診療所の推定・予測、2018～2030年
  • 外来手術センター
  • 画像診断センター
  • その他の用途

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア分析、2024年
  • Company Position Analysis
  • 企業分類（新興企業、イノベーター、リーダー）
  • 企業プロファイル
    • Siemens Healthineers
    • GE Healthcare
    • Koninklijke Philips NV
    • Canon Medical Systems
    • Fujifilm Holdings Corporation
    • Shanghai United Imaging Healthcare Co., LTD
    • Abbott
    • Terumo Corporation
    • Samsung Medison Co., Ltd.
    • Lepu Medical Technology
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 U.S. structural heart imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 3 U.S. structural heart imaging market, by procedure, 2018 - 2030 (USD Million)
  • Table 4 U.S. structural heart imaging market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. structural heart imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. structural heart imaging market: market outlook
  • Fig. 9 U.S. structural heart imaging market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. structural heart imaging market Driver Impact
  • Fig. 15 U.S. structural heart imaging market Restraint Impact
  • Fig. 16 U.S. structural heart imaging market Strategic Initiatives Analysis
  • Fig. 17 U.S. structural heart imaging market: modality Movement Analysis
  • Fig. 18 U.S. structural heart imaging market: modality outlook and key takeaways
  • Fig. 19 Echocardiogram market estimates and forecast, 2018 - 2030
  • Fig. 20 Angiogram market estimates and forecast, 2018 - 2030
  • Fig. 21 CT market estimates and forecast, 2018 - 2030
  • Fig. 22 MRI market estimates and forecast, 2018 - 2030
  • Fig. 23 Nuclear imaging market estimates and forecast, 2018 - 2030
  • Fig. 24 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 25 U.S. structural heart imaging market: modality movement analysis
  • Fig. 26 U.S. structural heart imaging market: modality outlook and key takeaways
  • Fig. 27 Echocardiogram market estimates and forecast, 2018 - 2030
  • Fig. 28 U.S. structural heart imaging market: procedure movement analysis
  • Fig. 29 U.S. structural heart imaging market: procedure outlook and key takeaways
  • Fig. 30 Echocardiogram market estimates and forecast, 2018 - 2030
  • Fig. 31 Transcatheter aortic valve replacement (TAVR) market estimates and forecast, 2018 - 2030
  • Fig. 32 Surgical aortic valve replacement (SAVR) market estimates and forecast, 2018 - 2030
  • Fig. 33 Transcatheter mitral valve repair (TMVR) market estimates and forecast, 2018 - 2030
  • Fig. 34 Left atrial appendage closure (LAAC) market estimates and forecast, 2018 - 2030
  • Fig. 35 Tricuspid valve replacement and repair market estimates and forecast, 2018 - 2030
  • Fig. 36 Paravalvular leak detection and repair market estimates and forecast, 2018 - 2030
  • Fig. 37 Annuloplasty market estimates and forecast, 2018 - 2030
  • Fig. 38 Valvuloplasty market estimates and forecast, 2018 - 2030
  • Fig. 39 Other structural heart procedures market estimates and forecast, 2018 - 2030
  • Fig. 40 U.S. structural heart imaging market: Application movement analysis
  • Fig. 41 U.S. structural heart imaging market: Application outlook and key takeaways
  • Fig. 42 Diagnostic imaging market estimates and forecast, 2018 - 2030
  • Fig. 43 Interventional cardiology market estimates and forecast, 2018 - 2030
  • Fig. 44 U.S. structural heart imaging market: End use Movement Analysis
  • Fig. 45 U.S. structural heart imaging market: End use outlook and key takeaways
  • Fig. 46 Hospitals & clinics market estimates and forecast, 2018 - 2030
  • Fig. 47 Ambulatory surgical centers market estimates and forecast, 2018 - 2030
  • Fig. 48 Diagnostic imaging centers market estimates and forecast, 2018 - 2030
  • Fig. 49 Other end use market estimates and forecast, 2018 - 2030
  • Fig. 50 Participant Categorization- U.S. structural heart imaging market
  • Fig. 51 Market share of key market players- U.S. structural heart imaging market
目次
Product Code: GVR-4-68040-498-7

U.S. Structural Heart Imaging Market Trends:

The U.S. structural heart imaging market size was estimated at USD 2.58 billion in 2024 and is expected to grow at a CAGR of 5.9% from 2025 to 2030. The rising prevalence of structural heart diseases, an aging population, and increasing adoption of minimally invasive procedures like TAVR and TMVR. Technological advancements such as 3D/4D echocardiography, AI-powered diagnostics, and fusion imaging have improved accuracy and efficiency in diagnosis and treatment planning. Expanding hospital infrastructure, increased awareness of early diagnosis, and collaborations between imaging companies and healthcare providers further fuel market growth.

The expansion of structural heart imaging in the U.S. is primarily driven by the growing prevalence of heart diseases and an increasing emphasis on preventive health checkups. Structural heart diseases, such as aortic stenosis, mitral regurgitation, and congenital heart defects, are becoming more common, particularly among the aging population, which is more vulnerable to these conditions. Early detection and accurate diagnosis are essential for managing these diseases effectively, fueling the demand for advanced imaging technologies. Simultaneously, patients are increasingly aware of the importance of preventive healthcare. People are increasingly opting for regular health screenings to detect potential cardiovascular issues before they become severe, which has led to a greater reliance on structural heart imaging solutions.

The presence of major manufacturers, such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V., is significantly driving market growth in the U.S. These industry leaders are consistently innovating and introducing advanced imaging products to meet the growing demand for accurate and efficient diagnostic solutions. For instance, in August 2024, Siemens Healthineers received FDA clearance for the ACUSON Origin, an advanced cardiovascular ultrasound system integrated with artificial intelligence (AI) capabilities. This advanced system is designed to enhance diagnostic accuracy and streamline workflows, demonstrating the industry's focus on leveraging AI to improve imaging outcomes. The continuous efforts of these key players to develop and commercialize new technologies not only cater to the rising prevalence of structural heart diseases but also strengthen the market's growth by offering healthcare providers state-of-the-art tools for patient care.

U.S. Structural Heart Imaging Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 - 2030. For the purpose of this study, Grand View Research has segmented the U.S. structural heart imaging market report on the basis of modality, procedure, application, and end-use:

  • Modality Outlook (Revenue, USD Million, 2018 - 2030)
  • Echocardiogram
  • Angiogram
  • CT
  • MRI
  • Nuclear Imaging
  • Other Modalities
  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Transcatheter Aortic Valve Replacement (TAVR)
  • Surgical Aortic Valve Replacement (SAVR)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Left Atrial Appendage Closure (LAAC)
  • Tricuspid Valve Replacement and Repair
  • Paravalvular Leak Detection and Repair
  • Annuloplasty
  • Valvuloplasty
  • Other Structural Heart Procedures
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Diagnostic Imaging
  • Interventional Cardiology
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Other End Use

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Modality
    • 1.1.2. Procedure
    • 1.1.3. Application
    • 1.1.4. End use
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. Application outlook
    • 2.2.4. End use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Structural Heart Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growing prevalence of cardiac diseases
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Increasing adoption of minimally invasive procedures
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of advanced imaging systems
      • 3.4.2.2. Stringent regulatory approvals
  • 3.5. U.S. Structural Heart Imaging Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. U.S. Structural Heart Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Structural Heart Imaging Modality Market Movement Analysis
  • 4.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by Modality, 2018 - 2030 (USD Million)
  • 4.4. Echocardiogram
    • 4.4.1. Echocardiogram market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Angiogram
    • 4.5.1. Angiogram market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. CT
    • 4.6.1. CT market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. MRI
    • 4.7.1. MRI market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Nuclear Imaging
    • 4.8.1. Nuclear imaging market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Other Modalities
    • 4.9.1. Other modalities market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. U.S. Structural Heart Imaging Market: Procedure Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Structural Heart Imaging Procedure Market Movement Analysis
  • 5.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by Procedure, 2018 - 2030 (USD Million)
  • 5.4. Transcatheter Aortic Valve Replacement (TAVR)
    • 5.4.1. Transcatheter Aortic Valve Replacement (TAVR) market estimates and forecast 2018 - 2030 (USD Million)
  • 5.5. Surgical Aortic Valve Replacement (SAVR)
    • 5.5.1. Surgical Aortic Valve Replacement (SAVR) market estimates and forecast 2018 - 2030 (USD Million)
  • 5.6. Transcatheter Mitral Valve Repair (TMVR)
    • 5.6.1. Transcatheter Mitral Valve Repair (TMVR) market estimates and forecast 2018 - 2030 (USD Million)
  • 5.7. Left Atrial Appendage Closure (LAAC)
    • 5.7.1. Left Atrial Appendage Closure (LAAC) market estimates and forecast 2018 - 2030 (USD Million)
  • 5.8. Tricuspid Valve Replacement and Repair
    • 5.8.1. Tricuspid Valve Replacement and Repair market estimates and forecast 2018 - 2030 (USD Million)
  • 5.9. Paravalvular Leak Detection and Repair
    • 5.9.1. Paravalvular Leak Detection and Repair market estimates and forecast 2018 - 2030 (USD Million)
  • 5.10. Annuloplasty
    • 5.10.1. Annuloplasty market estimates and forecast 2018 - 2030 (USD Million)
  • 5.11. Valvuloplasty
    • 5.11.1. Valvuloplasty market estimates and forecast 2018 - 2030 (USD Million)
  • 5.12. Other Structural Heart Procedures
    • 5.12.1. Other Structural Heart Procedures market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. U.S. Structural Heart Imaging Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Structural Heart Imaging Application Market Movement Analysis
  • 6.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
  • 6.4. Diagnostic Imaging
    • 6.4.1. Diagnostic imaging market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Interventional Cardiology
    • 6.5.1. Interventional cardiology market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. U.S. Structural Heart Imaging Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Structural Heart Imaging End Use Market Movement Analysis
  • 7.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 7.4. Hospitals & clinics
    • 7.4.1. Hospitals & clinics estimates and forecast 2018 - 2030 (USD Million)
  • 7.5. Ambulatory Surgical Centers
    • 7.5.1. Ambulatory surgical centers market estimates and forecast 2018 - 2030 (USD Million)
  • 7.6. Diagnostic Imaging Centers
    • 7.6.1. Diagnostic imaging centers market estimates and forecast 2018 - 2030 (USD Million)
  • 7.7. Other end use
    • 7.7.1. Other end use market estimates and forecast 2018 - 2030 (USD million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. Siemens Healthineers
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. GE Healthcare
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Koninklijke Philips N.V.
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Canon Medical Systems
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Fujifilm Holdings Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Shanghai United Imaging Healthcare Co., LTD
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Abbott
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Terumo Corporation
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Samsung Medison Co., Ltd.
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. Lepu Medical Technology
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives